Navigation Links
Federal Ethicon Trial Scheduled to Begin at the End of August in U.S. District Court, Southern District of West Virginia, Bernstein Liebhard LLP Reports
Date:8/14/2014

New York, NY (PRWEB) August 14, 2014

A bellwether trial in the federal Ethicon mesh litigation is scheduled to begin at the end of August in the U.S. District Court, Southern District of West Virginia, where thousands of transvaginal mesh lawsuits (http://www.injurybeacon.com/transvaginal-mesh/) are continuing to move forward, Bernstein Liebhard LLP reports.

According to court documents, the hearing will begin on August 25th, 2014, and will involve a woman who was allegedly injured by an implant marketed by the Johnson & Johnson subsidiary, Ethicon, Inc.
The outcome of this case will hopefully serve as an indicator of how future juries will rule in similar actions against the company. Court records indicate that over 21,000 lawsuits have now been filed over Ethicon mesh products in the Southern District of West Virginia. (In re: Ethicon, Inc., Pelvic Repair Systems Products Liability Litigation - MDL No. 2327)

“We are looking forward to the federal Ethicon litigation’s upcoming trial, as our Firm continues to hear from numerous women who were allegedly injured by transvaginal mesh,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free and confidential case evaluations to women who allegedly suffered serious injuries caused by products manufactured by Ethicon and other manufacturers.

Ethicon Mesh Litigation

Ethicon mesh lawsuits in the U.S. District Court, Southern District of West Virginia allege chronic pain, mesh erosion, organ damage and other complications stemming from use of the implants. Jeffrey S. Grand, a partner at Bernstein Liebhard LLP, is serving as on the Plaintiffs’ Steering Committee in the proceeding, which involves claims that Ethicon failed to adequately warn women about these risks in their marketing of the devices. The implants were defectively designed and inadequately tested prior to entering the U.S. market, plaintiffs similarly allege.

In addition to his work in the federal Ethicon mesh litigation, Mr. Grand is also serving on the Plaintiffs’ Steering Committee in several other proceedings in the U.S. District Court, Southern District of West Virginia. These litigations include: American Medical Systems, Inc. (MDL No. 2325); Boston Scientific Corp., (MDL No. 2326); and C.R. Bard, Inc., (MDL No. 2187).

Mr. Grand has also been appointed Co-Liaison Counsel in two vaginal mesh proceedings involving Ethicon and C.R. Bard in New Jersey’s Atlantic County Superior Court. Last year, he served as a member of the Plaintiffs’ trial team for the first trial in the Ethicon proceeding, which ended in March 2013 with an $11 million damage award to the plaintiff. This case involved a woman who suffered transvaginal mesh complications that occurred after receiving an Ethicon Gynecare Prolift implant. (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10; In re: Pelvic Mesh Litigation/Bard, No. L-6339-10)

Women who were allegedly injured by transvaginal mesh marketed by Ethicon or another company may be eligible to file a lawsuit that seeks compensation for lost wages, out-of-pocket medical expenses, pain and suffering and other damages. Visit Bernstein Liebhard LLP’s website to learn more about the ongoing transvaginal mesh litigations, or visit the Firm’s Facebook page: https://www.facebook.com/meshlawsuit. To obtain a free, confidential and no-obligation case review, please call 800-511-5092.

About Bernstein Liebhard LLP

Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.injurybeacon.com/
https://plus.google.com/115936073311125306742?rel=author

Read the full story at http://www.prweb.com/releases/ethicon-mesh-lawsuit/transvaginal-mesh-lawsuit/prweb12096073.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. The US Department of Justice Involved In A Whistleblower Lawsuit That Alleges Symantec Overcharged Federal and State Governments Tens of Millions Parker Waichman Comments
2. Partner Kristine Kraft Appointed to the Plaintiffs’ Steering Committee (PSC) in Federal Testosterone Replacement Therapy MDL, Schlichter, Bogard & Denton, LLP Reports
3. A Federal Appeals Court Overturned A Prior Ruling That Prevented Some WTC Cleanup Workers From Pursuing Undiagnosed Injury Claims, Parker Waichman LLP Comments
4. Lipitor Lawsuit News: Bernstein Liebhard LLP Notes Growing Number of Type 2 Diabetes Claims in Federal Lipitor Litigation
5. Federal Drug Discount Program faces challenges, report finds
6. DePuy Pinnacle Lawsuit News: New Pretrial Report Issued in Federal Pinnacle Hip Litigation, Bernstein Liebhard LLP Reports
7. Ethicon Transvaginal Mesh Lawsuit News: New Order Issued in Federal Litigation for Second Round of Bellwether Trials, Bernstein Liebhard LLP Reports
8. Byetta Lawsuit News: New Order Establishes Deposition Protocol For Federal Incretin Mimetics Litigation, Bernstein Liebhard LLP Reports
9. C.R. Bard Vaginal Mesh Lawsuits Move Forward, With Issuance of New Pretrial Order in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports
10. Tylenol Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Upcoming Conference in Federal Tylenol Liver Damage Litigation
11. Risperdal Lawsuits Mount, With Filing of New Gynecomastia Complaint in New York Federal Court, Bernstein Liebhard LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... 2017 , ... “The Trials I Face to Receive God’s Grace”: a ... aspirations and goals to better one’s life through God. “The Trials I Face to ... all the wrong places, found a love for writing. Green feels that expressing his ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... gathering of executive marketers this week about the value of senior executives, pointed ... that has happened in business has brought us to the present and will ...
(Date:9/20/2017)... ... September 20, 2017 , ... “They Sang At Her Funeral”: a ... murderer starts revealing the skeletons in their closets. “They Sang At Her Funeral” is ... fifty-six years young and married with five children and twelve grandchildren. Before becoming a ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... addition of strategic marketing leader, Denise Flannery, to its strategic advisory and client ... Management Consultant, Denise will work with clients across different industries to develop and ...
(Date:9/19/2017)... , ... September 19, 2017 ... ... that Scott McFarland has joined its executive team as the President of ... innovative value-based care management systems and contact centers. , “Scott is a ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... 6, 2017  Medical professionals are expected ... while treating their patients. Medical simulations offer ... involving patients. Simulation provides a safe method ... out procedures, refine techniques and build confidence, ... new technology, such as augmented reality, will ...
(Date:9/6/2017)... , Sept. 6, 2017 Eli Lilly ... it will present new data for galcanezumab and lasmiditan, ... of the International Headache Society (IHC) taking place Sept. ... Lilly will highlight new, long-term data from an ... doses of galcanezumab (120 mg and 240 mg) for ...
(Date:9/5/2017)... , Sept. 5, 2017  Getinge, a ... created a vibrant charitable donation program -- "Color ... support congenital heart defect research by The Children,s ... and the general public are encouraged to download ... submit the completed artwork to the gallery on ...
Breaking Medicine Technology: